This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (112)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Radiation Therapy  • Prostate Disease  • Oncology  • Prostate Cancer  • Alert me on articles by topic

Floyd J. Fowler, Jr, PhD; Mary McNaughton Collins, MD, MPH; Peter C. Albertsen, MD, MS; Anthony Zietman, MD; Diana B. Elliott, BA; Michael J. Barry, MD

JAMA. 2000;283:3217-3222.

Context  Multiple treatment options are available for men with prostate cancer, but therapeutic recommendations may differ depending on the type of specialist they consult.

Objective  To define and contrast the distribution of management recommendations by urologists and radiation oncologists for a spectrum of men with prostate cancer.

Design, Setting, and Participants  Mail survey sent in 1998 to a random sample of physicians in the United States, who were listed as urologists (response rate 64%, n=504) and radiation oncologists (response rate 76%, n=559) in the American Medical Association Registry of Physicians and practicing at least 20 hours per week.

Main Outcome Measure  Questionnaire addressing beliefs and practices regarding prostate cancer management.

Results  Forty-three percent of radiation oncologists vs 16% of urologists would recommend routine prostate-specific antigen testing for men aged 80 years and older. For men with moderately differentiated, clinically localized cancers, and a more than 10-year life expectancy, 93% of urologists chose radical prostatectomy as the preferred treatment option, while 72% of radiation oncologists believed surgery and external beam radiotherapy were equivalent treatments. For most tumor grades and prostate-specific antigen levels, both specialty groups were significantly more likely to recommend the treatment in their specialty than the other treatment. Both groups reported giving patients similar estimates of the risks of complications due to surgery and radiation. Neither group favored watchful waiting in their treatment management except for a subset of men with life expectancies of less than 10 years and cancers with very favorable prognoses (Gleason score of 3 or 4 and prostate-specific antigen level 5 ng/mL).

Conclusions  Based on this study, while urologists and radiation oncologists do agree on a variety of issues regarding detection and treatment of prostate cancer, specialists overwhelmingly recommend the therapy that they themselves deliver.

Author Affiliations: Center for Survey Research, University of Massachusetts, Boston (Dr Fowler and Ms Elliott); Medical Practices Evaluation Center (Drs McNaughton Collins and Barry) and the Department of Radiation Oncology (Dr Zietman), Massachusetts General Hospital, Boston; and the Division of Urology, University of Connecticut Health Center, Farmington (Dr Albertsen).

RELATED ARTICLES

Uncertainty in Prostate Cancer Care: The Physician's Role in Clearing the Confusion
Timothy J. Wilt
JAMA. 2000;283(24):3258-3260.
EXTRACT | FULL TEXT  

June 28, 2000
JAMA. 2000;283(24):3317-3318.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer
Walz et al.
JCO 2007;25:3576-3581.
ABSTRACT | FULL TEXT  

Case 18-2007 -- A 54-Year-Old Man with Early-Stage Prostate Cancer
Kaufman et al.
NEJM 2007;356:2515-2520.
FULL TEXT  

Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising
Jagsi
JCO 2007;25:902-905.
FULL TEXT  

Clinically localised prostate cancer
Wilt and Thompson
BMJ 2006;333:1102-1106.
FULL TEXT  

Confidence and Uncertainty Long After Initial Treatment for Early Prostate Cancer: Survivors' Views of Cancer Control and the Treatment Decisions They Made
Clark and Talcott
JCO 2006;24:4457-4463.
ABSTRACT | FULL TEXT  

Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
Potosky et al.
JNCI J Natl Cancer Inst 2004;96:1358-1367.
ABSTRACT | FULL TEXT  

Case 21-2004 - A 63-Year-Old Man with Metastatic Prostate Carcinoma Refractory to Hormone Therapy
Kaufman et al.
NEJM 2004;351:171-178.
FULL TEXT  

Genotoxic Stress Induces Expression of E2F4, Leading to Its Association with p130 in Prostate Carcinoma Cells
DuPree et al.
Cancer Res. 2004;64:4390-4393.
ABSTRACT | FULL TEXT  

Patient Education Materials about the Treatment of Early-Stage Prostate Cancer: A Critical Review
Fagerlin et al.
ANN INTERN MED 2004;140:721-728.
ABSTRACT | FULL TEXT  

Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians
Ng et al.
Ann Oncol 2004;15:261-269.
ABSTRACT | FULL TEXT  

Ethics of clinical trials from bayesian perspective: Medical decision making should use posteriors, not priors
Frankel et al.
BMJ 2003;326:1456-1456.
FULL TEXT  

Quality of Care in Prostate Cancer: Important to Start and Too Important to Stop Here
Talcott
JCO 2003;21:1902-1903.
FULL TEXT  

Elective Management of the Clinically Negative Neck by Otolaryngologists in Patients With Oral Tongue Cancer
Werning et al.
Arch Otolaryngol Head Neck Surg 2003;129:83-88.
ABSTRACT | FULL TEXT  

Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck et al.
NEJM 2002;347:790-796.
ABSTRACT | FULL TEXT  

Palliative Chemotherapy or Watchful Waiting? A Vignettes Study Among Oncologists
Koedoot et al.
JCO 2002;20:3658-3664.
ABSTRACT | FULL TEXT  

Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience With Radical Prostatectomy and External-Beam Radiotherapy
Kupelian et al.
JCO 2002;20:3376-3385.
ABSTRACT | FULL TEXT  

Comparing the Costs of Radiation Therapy and Radical Prostatectomy for the Initial Treatment of Early-Stage Prostate Cancer
Burkhardt et al.
JCO 2002;20:2869-2875.
ABSTRACT | FULL TEXT  

Physician Specialty Is Associated With Differences in the Evaluation and Management of Acute Bacterial Rhinosinusitis
Werning et al.
Arch Otolaryngol Head Neck Surg 2002;128:123-130.
ABSTRACT | FULL TEXT  

Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study
Harlan et al.
JNCI J Natl Cancer Inst 2001;93:1864-1871.
ABSTRACT | FULL TEXT  

Screening for prostate cancer in the UK
Donovan et al.
BMJ 2001;323:763-764.
FULL TEXT  

Prostate-Specific-Antigen Testing for Early Diagnosis of Prostate Cancer
Barry
NEJM 2001;344:1373-1377.
FULL TEXT  

Centrosome Defects Can Account for Cellular and Genetic Changes That Characterize Prostate Cancer Progression
Pihan et al.
Cancer Res. 2001;61:2212-2219.
ABSTRACT | FULL TEXT  

Uncertainty in Prostate Cancer Care: The Physician's Role in Clearing the Confusion
Wilt
JAMA 2000;283:3258-3260.
FULL TEXT